
Procter & Gamble (PGHH) | Financial Analysis & Statements
TL;DR: Financial Overview - Revenue, Profits & Key Metrics
Latest Quarterly: Mar 2025Income Metrics
Revenue
9.9B
Gross Profit
5.9B
60.09%
Operating Income
2.0B
20.15%
Net Income
1.6B
15.78%
EPS (Diluted)
₹48.09
Balance Sheet Metrics
Total Assets
17.5B
Total Liabilities
10.2B
Shareholders Equity
7.4B
Debt to Equity
1.38
Cash Flow Metrics
Operating Cash Flow
2.7B
Free Cash Flow
455.0M
Revenue & Profitability Trend
Procter & Gamble Income Statement From 2020 to 2024
Metric | 2024 | 2023 | 2022 | 2021 | 2020 |
---|---|---|---|---|---|
Revenue | 41.9B | 39.1B | 37.9B | 35.7B | 30.0B |
Cost of Goods Sold | 18.4B | 16.6B | 17.6B | 13.3B | 12.7B |
Gross Profit | 23.5B | 22.4B | 20.3B | 22.4B | 17.2B |
Gross Margin % | 56.1% | 57.4% | 53.5% | 62.8% | 57.5% |
Operating Expenses | |||||
Research & Development | - | - | - | - | - |
Selling, General & Administrative | 6.6B | 4.3B | 6.1B | 6.4B | 4.2B |
Other Operating Expenses | 4.6B | 7.5B | 4.6B | 5.1B | 4.9B |
Total Operating Expenses | 11.2B | 11.8B | 10.8B | 11.5B | 9.1B |
Operating Income | 9.5B | 8.1B | 7.9B | 8.6B | 5.9B |
Operating Margin % | 22.6% | 20.7% | 20.9% | 24.0% | 19.8% |
Non-Operating Items | |||||
Interest Income | 452.2M | 362.1M | 242.9M | 322.9M | 338.5M |
Interest Expense | 267.8M | 113.8M | 111.9M | 61.1M | 60.7M |
Other Non-Operating Income | - | - | - | - | - |
Pre-tax Income | 9.4B | 8.4B | 7.9B | 8.7B | 5.9B |
Income Tax | 2.6B | 1.6B | 2.1B | 2.2B | 1.6B |
Effective Tax Rate % | 28.1% | 19.2% | 27.1% | 25.1% | 27.1% |
Net Income | 6.8B | 6.8B | 5.8B | 6.5B | 4.3B |
Net Margin % | 16.1% | 17.4% | 15.2% | 18.3% | 14.4% |
Key Metrics | |||||
EBITDA | 10.5B | 9.1B | 8.6B | 9.4B | 6.8B |
EPS (Basic) | ₹207.95 | ₹208.91 | ₹177.37 | ₹200.79 | ₹133.42 |
EPS (Diluted) | ₹207.95 | ₹208.91 | ₹177.37 | ₹200.79 | ₹133.42 |
Basic Shares Outstanding | 32460736 | 32460868 | 32460736 | 32460736 | 32460736 |
Diluted Shares Outstanding | 32460736 | 32460868 | 32460736 | 32460736 | 32460736 |
Income Statement Trend
Procter & Gamble Balance Sheet From 2020 to 2024
Metric | 2024 | 2023 | 2022 | 2021 | 2020 |
---|---|---|---|---|---|
Assets | |||||
Current Assets | |||||
Cash & Equivalents | 5.7B | 9.6B | 6.2B | 6.5B | 8.8B |
Short-term Investments | 1.0B | 469.3M | 142.7M | 125.7M | - |
Accounts Receivable | 2.4B | 2.2B | 1.9B | 1.4B | 1.7B |
Inventory | 2.3B | 2.2B | 2.3B | 2.5B | 2.1B |
Other Current Assets | 519.6M | 451.7M | 437.1M | 345.2M | - |
Total Current Assets | 12.0B | 15.0B | 11.4B | 11.2B | 13.3B |
Non-Current Assets | |||||
Property, Plant & Equipment | 1.4B | 156.8M | 160.8M | 160.8M | 151.5M |
Goodwill | - | - | - | - | - |
Intangible Assets | - | - | - | - | - |
Long-term Investments | - | - | - | - | - |
Other Non-Current Assets | 1.2B | 1.0B | 725.3M | 579.3M | - |
Total Non-Current Assets | 6.6B | 6.4B | 5.5B | 5.2B | 5.0B |
Total Assets | 18.6B | 21.4B | 16.8B | 16.3B | 18.3B |
Liabilities | |||||
Current Liabilities | |||||
Accounts Payable | 8.5B | 9.7B | 7.8B | 7.5B | 5.3B |
Short-term Debt | 30.7M | 31.9M | 31.6M | 32.9M | 35.7M |
Current Portion of Long-term Debt | - | - | - | - | - |
Other Current Liabilities | 479.1M | 493.4M | 403.8M | 366.1M | - |
Total Current Liabilities | 9.8B | 10.9B | 8.6B | 8.4B | 6.0B |
Non-Current Liabilities | |||||
Long-term Debt | 100.0K | 8.4M | 19.4M | 1.8M | 14.7M |
Deferred Tax Liabilities | - | - | - | - | - |
Other Non-Current Liabilities | -100.0K | - | - | - | - |
Total Non-Current Liabilities | 1.0B | 1.1B | 853.7M | 829.8M | 754.9M |
Total Liabilities | 10.8B | 11.9B | 9.4B | 9.2B | 6.7B |
Equity | |||||
Common Stock | 324.6M | 324.6M | 324.6M | 324.6M | 324.6M |
Retained Earnings | 3.0B | 4.8B | 2.8B | 2.7B | 7.2B |
Treasury Stock | - | - | - | - | - |
Other Equity | - | - | - | - | - |
Total Shareholders Equity | 7.7B | 9.5B | 7.4B | 7.1B | 11.6B |
Key Metrics | |||||
Total Debt | 30.8M | 40.3M | 51.0M | 34.7M | 50.4M |
Working Capital | 2.2B | 4.1B | 2.8B | 2.8B | 7.3B |
Balance Sheet Composition
Procter & Gamble Cash Flow Statement From 2020 to 2024
Metric | 2024 | 2023 | 2022 | 2021 | 2020 |
---|---|---|---|---|---|
Operating Activities | |||||
Net Income | 9.4B | 8.4B | 7.9B | 8.7B | 5.9B |
Depreciation & Amortization | - | - | - | - | - |
Stock-Based Compensation | 85.0M | 84.8M | 101.5M | 69.5M | 52.5M |
Working Capital Changes | -1.3B | -488.0M | -609.3M | -311.6M | 38.9M |
Operating Cash Flow | 7.8B | 7.8B | 7.2B | 8.2B | 5.8B |
Investing Activities | |||||
Capital Expenditures | -432.7M | -444.2M | -497.3M | -314.6M | -503.4M |
Acquisitions | - | - | - | - | - |
Investment Purchases | - | - | - | - | - |
Investment Sales | - | - | - | - | - |
Investing Cash Flow | -432.7M | -444.2M | -497.3M | -236.2M | -566.1M |
Financing Activities | |||||
Share Repurchases | - | - | - | - | - |
Dividends Paid | -8.6B | -4.7B | -5.7B | -11.0B | -1.9B |
Debt Issuance | - | - | - | - | - |
Debt Repayment | - | - | - | - | - |
Financing Cash Flow | -8.6B | -4.7B | -5.7B | -11.0B | -1.9B |
Free Cash Flow | 4.3B | 7.8B | 5.2B | 8.3B | 4.2B |
Net Change in Cash | -1.2B | 2.6B | 1.1B | -3.1B | 3.3B |
Cash Flow Trend
Procter & Gamble Key Financial Ratios
Valuation Ratios
P/E Ratio (TTM)
59.88
Forward P/E
45.20
Price to Book
58.24
Price to Sales
9.97
PEG Ratio
45.20
Profitability Ratios
Profit Margin
16.67%
Operating Margin
27.44%
Return on Equity
80.21%
Return on Assets
36.32%
Financial Health
Current Ratio
1.23
Debt to Equity
0.32
Beta
0.17
Per Share Data
EPS (TTM)
₹220.82
Book Value per Share
₹227.05
Revenue per Share
₹1,326.56
Peer Financial Comparison
Company | Market Cap | P/E Ratio | P/B Ratio | ROE | Profit Margin | Debt/Equity |
---|---|---|---|---|---|---|
pghh | 429.2B | 59.88 | 58.24 | 80.21% | 16.67% | 0.32 |
Hindustan Unilever | 5.9T | 54.56 | 11.93 | 21.47% | 16.89% | 3.32 |
Godrej Consumer | 1.2T | 65.35 | 10.11 | 15.43% | 12.62% | 33.69 |
Marico | 912.5B | 54.65 | 22.92 | 38.19% | 14.58% | 12.99 |
Dabur India | 904.8B | 50.81 | 8.37 | 15.77% | 14.12% | 8.48 |
Colgate-Palmolive | 601.9B | 43.17 | 36.13 | 86.32% | 23.31% | 3.66 |
Financial data is updated regularly. All figures are in the company's reporting currency.